Analyst Research

Report Title Price
Thomson Reuters Stock Report - CHIOME BIOSCIENCE INC (4583-TO)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Chiome Bioscience, Inc. (4583) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Chiome Bioscience Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Chiome Bioscience FY03/13 Flash Update
Provider: Shared Research Inc.
$0.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Gazprom gazoraspredeleniye OAO Receives Permission to Acquire 55.26% in Tulagorgaz ZAO-AK&M


Sunday, 27 Jan 2013 07:00pm EST 

AK&M reported that Gazprom gazoraspredeleniye OAO has received a permission from the Federal Antimonopoly Service of Russia (FAS) to acquire a 55.26% shares in Tulagorgaz ZAO. As a result, the Company is to increase its stake in Tulagorgaz ZAO to 86.375%. Tulagorgaz ZAO is primarily engaged in the delivery, transportation and sale of gas. 

Latest Developments for Chiome Bioscience Inc

Latest Key Developments in Pharmaceuticals

Company Quote

Chiome Bioscience Inc
(4583.T)
10250.0
-1250.0 -10.87%
2:00am EDT